Mouwasat posts higher net profit at SAR 150.8mln in I3 of 2013

Mouwasat posts higher net profit at SAR 150.8mln in I3 of 2013

30/09/2013 Argaam Exclusive

View other reports

 

Mouwasat Medical Services Co., active in the operation and management of hospitals and medical clinics, reported SAR 150.8mln net profit at the end of I3 of 2013, a 17% increase compared to the same period last year.



Financials (M)

Item 9m 2012 9m 2013 Change‬
Revenues 583.48 659.60 13.0 %
Gross Income 271.61 331.63 22.1 %
Operating Income 142.31 167.04 17.4 %
Net Income 129.03 150.79 16.9 %
Average Shares 200.00 200.00 -
EPS (Riyals) 0.65 0.75 16.9 %


Current Quarter Comparison (M)

Compared With The
Item Q3 2012 Q3 2013 Change‬
Revenues 187.28 211.63 13.0 %
Gross Income 84.01 104.34 24.2 %
Operating Income 37.08 48.82 31.7 %
Net Income 35.44 44.11 24.5 %
Average Shares 200.00 200.00 -
EPS (Riyals) 0.18 0.22 24.5 %


Financial results (Million)

Period Revenues Change Gross Income Change Net Income Change EPS(Riyal)
Q1 2004 - - - - - - -
Q2 2004 - - - - - - -
Q3 2004 - - - - - - -
Q4 2004 - - - - - - -
Q1 2005 - - - - - - -
Q2 2005 - - - - - - -
Q3 2005 - - - - - - -
Q4 2005 - - - - - - -
Q1 2006 - - - - - - -
Q2 2006 - - - - - - -
Q3 2006 - - - - - - -
Q4 2006 - - - - - - -
Q1 2007 - - - - - - -
Q2 2007 - - - - - - -
Q3 2007 - - - - - - -
Q4 2007 - - - - - - -
Q1 2008 113.83 - 52.37 - 25.90 - 0.13
Q2 2008 118.48 - 53.79 - 26.63 - 0.13
Q3 2008 104.92 - 47.23 - 20.47 - 0.10
Q4 2008 117.32 - 47.51 - 24.07 - 0.12
Q1 2009 124.60 9.5 % 56.25 7.4 % 26.55 2.5 % 0.13
Q2 2009 140.62 18.7 % 67.77 26.0 % 34.03 27.8 % 0.17
Q3 2009 115.21 9.8 % 54.05 14.4 % 21.88 6.9 % 0.11
Q4 2009 137.16 16.9 % 49.94 5.1 % 24.58 2.1 % 0.12
Q1 2010 143.79 15.4 % 68.04 21.0 % 32.37 21.9 % 0.16
Q2 2010 148.78 5.8 % 71.36 5.3 % 34.77 2.2 % 0.17
Q3 2010 134.72 16.9 % 63.30 17.1 % 23.14 5.8 % 0.12
Q4 2010 160.20 16.8 % 74.36 48.9 % 28.28 15.1 % 0.14
Q1 2011 166.82 16.0 % 84.05 23.5 % 39.14 20.9 % 0.20
Q2 2011 164.93 10.9 % 76.76 7.6 % 40.49 16.4 % 0.20
Q3 2011 156.92 16.5 % 74.10 17.1 % 33.71 45.7 % 0.17
Q4 2011 189.77 18.5 % 89.09 19.8 % 34.72 22.8 % 0.17
Q1 2012 195.57 17.2 % 94.32 12.2 % 46.34 18.4 % 0.23
Q2 2012 200.62 21.6 % 93.28 21.5 % 47.26 16.7 % 0.24
Q3 2012 187.28 19.3 % 84.01 13.4 % 35.44 5.1 % 0.18
Q4 2012 213.04 12.3 % 101.10 13.5 % 42.56 22.6 % 0.21
Q1 2013 219.23 12.1 % 110.39 17.0 % 52.52 13.3 % 0.26
Q2 2013 228.74 14.0 % 116.90 25.3 % 54.16 14.6 % 0.27
Q3 2013 211.63 13.0 % 104.34 24.2 % 44.11 24.5 % 0.22

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
Q1 2004 - - -
Q2 2004 - - -
Q3 2004 - - -
Q4 2004 - - -
Q1 2005 - - -
Q2 2005 - - -
Q3 2005 - - -
Q4 2005 - - -
Q1 2006 - - -
Q2 2006 - - -
Q3 2006 - - -
Q4 2006 - - -
Q1 2007 - - -
Q2 2007 - - -
Q3 2007 - - -
Q4 2007 - - -
Q1 2008 - - -
Q2 2008 - - -
Q3 2008 - - -
Q4 2008 44.20 % 30.76 % 21.36 %
Q1 2009 44.01 % 30.89 % 21.00 %
Q2 2009 44.88 % 32.07 % 21.57 %
Q3 2009 45.32 % 32.67 % 21.40 %
Q4 2009 44.05 % 30.06 % 20.68 %
Q1 2010 44.67 % 30.72 % 21.03 %
Q2 2010 44.66 % 30.02 % 20.85 %
Q3 2010 44.76 % 28.94 % 20.35 %
Q4 2010 47.16 % 30.15 % 20.18 %
Q1 2011 48.00 % 29.97 % 20.53 %
Q2 2011 47.63 % 29.54 % 20.91 %
Q3 2011 47.66 % 30.31 % 21.83 %
Q4 2011 47.76 % 30.40 % 21.82 %
Q1 2012 47.27 % 30.32 % 21.95 %
Q2 2012 47.22 % 30.30 % 21.81 %
Q3 2012 46.65 % 28.88 % 21.18 %
Q4 2012 46.79 % 28.28 % 21.54 %
Q1 2013 47.40 % 28.13 % 21.68 %
Q2 2013 48.62 % 28.20 % 21.77 %
Q3 2013 49.59 % 28.72 % 22.16 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
Q1 2004 - - - -
Q2 2004 - - - -
Q3 2004 - - - -
Q4 2004 - - - -
Q1 2005 - - - -
Q2 2005 - - - -
Q3 2005 - - - -
Q4 2005 - - - -
Q1 2006 - - - -
Q2 2006 - - - -
Q3 2006 - - - -
Q4 2006 - - - -
Q1 2007 - - - -
Q2 2007 - - - -
Q3 2007 - - - -
Q4 2007 - - - -
Q1 2008 200.00 - - 1.90
Q2 2008 200.00 - - 1.92
Q3 2008 200.00 - - 2.02
Q4 2008 200.00 0.49 0.49 2.05
Q1 2009 200.00 0.49 0.49 2.18
Q2 2009 200.00 0.53 0.53 2.27
Q3 2009 200.00 0.53 0.53 2.28
Q4 2009 200.00 0.54 0.54 2.40
Q1 2010 200.00 0.56 0.56 2.56
Q2 2010 200.00 0.57 0.57 2.61
Q3 2010 200.00 0.57 0.57 2.72
Q4 2010 200.00 0.59 0.59 2.86
Q1 2011 200.00 0.63 0.63 3.06
Q2 2011 200.00 0.66 0.66 3.01
Q3 2011 200.00 0.71 0.71 3.18
Q4 2011 200.00 0.74 0.74 3.34
Q1 2012 200.00 0.78 0.78 3.57
Q2 2012 200.00 0.81 0.81 3.44
Q3 2012 200.00 0.82 0.82 3.61
Q4 2012 200.00 0.86 0.86 3.82
Q1 2013 200.00 0.89 0.89 4.08
Q2 2013 200.00 0.92 0.92 3.98
Q3 2013 200.00 0.97 0.97 4.20

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
Q1 2004 - - -
Q2 2004 - - -
Q3 2004 - - -
Q4 2004 - - -
Q1 2005 - - -
Q2 2005 - - -
Q3 2005 - - -
Q4 2005 - - -
Q1 2006 - - -
Q2 2006 - - -
Q3 2006 - - -
Q4 2006 - - -
Q1 2007 - - -
Q2 2007 - - -
Q3 2007 - - -
Q4 2007 - - -
Q1 2008 - - -
Q2 2008 - - -
Q3 2008 - - -
Q4 2008 - - -
Q1 2009 - - -
Q2 2009 - - -
Q3 2009 14.20 14.20 3.31
Q4 2009 14.31 14.31 3.19
Q1 2010 13.68 13.68 3.02
Q2 2010 14.64 14.64 3.19
Q3 2010 14.75 14.75 3.11
Q4 2010 15.18 15.18 3.15
Q1 2011 13.52 13.52 2.77
Q2 2011 16.08 16.08 3.50
Q3 2011 13.29 13.29 2.96
Q4 2011 15.92 15.92 3.53
Q1 2012 16.83 16.83 3.66
Q2 2012 13.89 13.89 3.27
Q3 2012 15.57 15.57 3.53
Q4 2012 15.66 15.66 3.52
Q1 2013 18.00 18.00 3.92
Q2 2013 18.62 18.62 4.32
Q3 2013 21.21 21.21 4.88

Business Segments (Million)

Compared With The
Period Medical Services Pharmaceutical Products Administration Fees
Q1 2008 86.60 26.81 0.43
Q2 2008 91.71 26.38 0.40
Q3 2008 84.21 20.23 0.47
Q4 2008 84.07 31.65 1.61
Q1 2009 94.61 29.63 0.36
Q2 2009 105.22 28.44 6.97
Q3 2009 92.73 26.15 (3.67)
Q4 2009 103.72 33.04 0.40
Q1 2010 109.41 32.47 1.92
Q2 2010 114.73 34.05 -
Q3 2010 102.85 31.87 -
Q4 2010 118.91 41.29 -
Q1 2011 129.63 37.19 -
Q2 2011 128.04 36.89 -
Q3 2011 123.09 33.84 -
Q4 2011 149.24 40.52 -
Q1 2012 155.38 40.19 -
Q2 2012 159.24 41.38 -
Q3 2012 149.51 37.77 -
Q4 2012 168.11 44.93 -
Q1 2013 177.18 42.05 -
Q2 2013 186.71 42.02 -
Q3 2013 172.61 39.02 -


Financial Ratios
Current
Market Cap (M Riyal) 24,000.00
Enterprise Value (EV) (M) 24,652.78
Shares Outstanding ((M)) 200.00
EPS ( Riyal) (TTM) 3.31
Book Value (BV) ( Riyal) 17.24
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) 36.22
P/E (TTM) 36.22
Price/book 6.96
Return on Average Assets (%) (TTM) 13.0
Return on Average Equity (%) (TTM) 20.3
more

Share Price

Mouwasat Medical Services Co.
120.20
0.20 0.17 %

Mouwasat Medical Services Co. (MOUWASAT)

More

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.